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1. INTRODUCTION 
The organophosphorus compound soman (me- 
thylphosphonofluoridic acid 1,2,2-trimethylpropyl 
ester) is a potent cholinesterase inhibitor [1,2] and 
a chemical warfare agent. The rapid identification 
and characterization of nerve agents such as soman 
would facilitate the diagnosis and treatment of 
poisoned humans, and provide a more useful 
means of environmental surveillance. Presently, 
soman is routinely identified by physicochemical 
techniques such as gas chromatography [3-51. 
Though sensitive and specific, these techniques are 
time consuming and require expensive equipment 
and highly trained operators. Here, we discuss the 
production of a mouse monoclonal antibody that 
binds to soman and further describe the use of this 
antibody in a competitive inhibition enzyme im- 
munoassay (CIEIA) capable of quantifying levels 
of soman as low as 1.0 x 10v6M (200ppb). The 
specificity of this antibody is demonstrated by its 
ability to distinguish between soman and the 
structurally similar organophosphorus nerve agent 
sarin (methylphosphonofluoridic acid, l-isopropyl 
ester). 
hemocyanin from giant keyhole limpets (KLH) was 
purchased from Schwarz-Mann (Orangeberg NY). 
Soman and sarin (>95% pure) were obtained from 
Chemical Systems Labs. (Aberdeen Proving 
Ground MD). All other chemicals were reagent 
grade and obtained commercially. 
2.2. Preparation of immunogenic soman-protein 
conjugates 
Soman is non-immunogenic by virtue of its very 
low &value. To induce antibody production, 
soman was conjugated to BSA and KLH by 
diazotization as in [a]. The method in [7] was used 
to determine the epitope density (mol soman 
bound/mol protein). For soman-KLH and 
soman-BSA the values were 700 and 15, respec- 
tively. The structure of the immunogen is shown in 
fig. 1. 
2.3. Hybridomas 
2. EXPERIMENTAL 
2.1, Chemicals 
Crystallized bovine serum albumin (BSA) was 
obtained from Miles Labs. (Kankakee IL) and 
Adult female BALB/c mice (Jackson Labs., Bar 
Harbor ME) were immunized subcutaneously with 
1OOrg (protein) of soman-BSA emulsified in com- 
plete Freund’s adjuvant. Fourteen days later the 
mice received a booster immunization of 1OOpg 
soman-BSA in normal saline by the intra- 
peritoneal route. After 3 days, spleens were remov- 
ed and splenic lymphocytes fused with the hypo- 
xanthine-guanine phosphoribosyltransferase defi- 
cient mouse plasmacytoma line P3-X63- 
Ag8.653 [8] as in [9], with some modifications. Fu- 
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Fig. 1. Structure of soman-pro&n conjugates mployed 
for immunization and/or immunoassay. 
sion was accomplished with 35% polyethylene 
glycol (Mr 1400, American Type Culture Collec- 
tion, Rockville MD), and fused cells planted in 
96-well, sterile, flat-bottomed microtiter plates at 
5.0 x 10’ cells/well. Hybridomas were selected in 
hypoxanthine-aminopterin-thymidine medium 
for the first week, with changes of culture medium 
on alternate days. 
2.4. Enzyme immunoassay and cloning 
Supernatants from 1Cday hybridoma cultures 
were analyzed for anti-soman antibody production 
by enzyme immunoassay [lO,ll]. Wells of flat- 
bottomed polystyrene microtiter plates (Dynatech, 
Alexandria VA) were incubated with 100~1 
soman-KLH (lOpg/ml in 0.1 M NaHCO3, pH 9.6) 
overnight at 4°C. These plates were washed with 
Dulbecco’s phosphate-buffered saline (Flow 
Labs., Vienna VA) containing 0.5% Tween 20 
(PBS-T) by 5 repetitions of filling and emptying 
each well. Aliquots of hybridoma supernatants 
(100,ul) were added to soman-KLH coated wells in 
duplicate and incubated for 30 min at room 
temperature. Unbound antibody was washed away 
as above and 100~1 aliquots of rabbit anti-mouse 
x light chain antiserum (1: 300 in PBS-T, Miles 
Labs., Elkhardt IN) was added and incubated for 
30 min at room temperature. This reagent binds to 
virtually all mouse immunoglobulin classes and 
subclasses. Unbound rabbit antibody was washed 
away and 100~1 aliquots of alkaline 
phosphatase-conjugated goat anti-rabbit IgG 
(1: 500 in PBS-T, Sigma Chemical Co., St Louis 
MO) was added. Following a 30 min incubation at 
room temperature and a final wash, 100~1 enzyme 
substrate (p-nitrophenylphosphate, 1 mg/ml in 
10% diethanolamine buffer (pH 9.6), Sigma 
Chemical Co., St Louis MO) was added. The en- 
zymatic reaction was allowed to proceed for 30 min 
at room temperature, then the colored reaction 
product was measured spectrophotometrically at 
405 nm in a Titertek@ Multiscan Micro-ELISA 
Reader (Flow Labs., Vienna VA). Duplicate deter- 
minations > 4-times background (absorbance of 
tissue culture medium on antigen-coated wells) 
were considered to be positive. 
Positive supernatants were further screened for 
reactivity to free soman by a modified CIEIA [ 121. 
An aliquot of 100~1 positive supernatant was in- 
cubated for 1 h with 100~1 PBS-T or PBS-T con- 
taining 2.0 x 10w3M soman. Of this mixture, 
100~1 was tested for antibody binding exactly as 
above. Inhibition of >50% of the control absor- 
bance was considered indicative of reactivity with 
free soman. Hybridoma cultures with supernatants 
that tested positive by CIEIA were cloned by 
limiting dilution (0.5-l cell/well) on irradiated 
mouse tumor macrophage (P388Dl) feeder layers. 
Clones were further tested by enzyme immuno- 
assay and positive clones recloned as before. 
One clone designated A10 was chosen for de- 
tailed analysis. A10 was found to be of the IgGl 
subclass by Ouchterlony double diffusion against 
mouse immunoglobulin class- and subclass-specific 
reagents (Miles Labs., Elkhardt IN). The cloned 
hybridomas were cryopreserved in 15% dimethyl- 
sulfoxide, 85% RPM1 1640 medium (containing 
10% fetal bovine serum) and stored in liquid 
nitrogen vapor phase. Long term cultures were 
established and antibody harvested by protein 
A-Sepharose affinity chromatography [131. 
2.3. CZEZA 
An assay system similar to that in [12] was em- 
ployed. In the CIEIA, a concentration of mono- 
clonal anti-soman antibody that bound to <lOO% 
of the available site on the solid phase bound 
soman-KLH was mixed with equal volumes of 
soman in log molar dilutions, then incubated 
for 1 h at room temperature. The remainder of 
the assay was exactly as above for hybridoma 
screening. 
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3. RESULTS 
3.1. Generation of hybridomas secreting 
antisoman antibodies 
In the initial screen, supernatants from all wells 
with growing hybridomas were tested for antibody 
that bound to soman conjugate. For the fusion 
that yielded AlO, 24 of 384 wells (6%) were 
positive for anti-soman antibody. However, when 
these positives were further tested for reactivity to 
free soman (by CIEIA), only 4 were positive. This 
discrepancy has now been noted in several fusion 
experiments, and suggests that antibodies directed 
against the spacer unit or the diazo bond occur 
with some regularity. Since reactivity with uncon- 
jugated soman is critical for developing an immu- 
noassay system, the CIEIA screen is all important. 
3.2. Titration of anti-soman antibody on 
soman-KLH 
To determine the non-saturating concentration 
of anti-soman antibody for use in the CIEIA, the 
binding of various concentrations of anti-soman to 
soman-KLH was assessed (fig. 2A). The concen- 
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Fig. 2. (A) Titration of the binding of anti-soman to 
soman-KLH. (B) Inhibition of the binding of anti- 
soman antibody to soman-KLH by various concentra- 
tions of free soman. 
tration chosen for routine assay was 2rg/ml, a 
value that was near the midpoint of the linear seg- 
ment of the dilution curve. 
3.3. Detection limits in the CIEIA 
In the CIEIA, the inhibition of binding of anti- 
soman antibody to soman-KLH by various con- 
centrations of free soman was used to generate a 
standard curve from which unknown concentra- 
tions of soman could be quantified. Fig. 2B il- 
lustrates a typical soman inhibition curve. Note 
that the curve is linear from 1.0 x 10m3 M to 
-1 .O x 10e6 M, thus allowing the quantification 
of soman in test samples over a 3 log range. The 
maximum sensitivity of the CIEIA would be defin- 
ed by the lowest soman concentration that gives a 
linear inhibition. 
The specificity of the anti-soman antibody was 
assessed by comparing the inhibition induced by 
soman with a related organophosphorus nerve 
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Fig. 3. Specificity of binding of anti-soman antibody to 
soman-KLH. The ability of soman (O--O) to inhibit 
binding of anti-soman antibody to soman-KLH was 
compared with a related organophosphorus nerve agent, 
sarin (O-_-O). The absorbance generated in the absence 
of either inhibitor represents 100%. 
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agent, sarin. Fig. 3 shows that sarin failed to in- 
hibit anti-soman binding to soman-KLH. 
4. DISCUSSION 
This study describes the preparation of the first 
monoclonal antibody to an organophosphorus 
nerve agent. The feasibility of preparing im- 
munogenic conjugates between small chemicals 
and carrier proteins is well documented [14]; the 
conjugates used here had been shown to be immu- 
nogenic in rabbits [6]. 
The use of two immunologically distinct carrier 
proteins for immunization and screening cir- 
cumvented the problem of anti-carrier antibody, 
but did not conclusively identify antibodies reac- 
tive with free soman. The most likely explanation 
for this result is the induction of antibodies that 
recognize all or part of the p-aminophenyl spacer 
or the diazo bond. Nevertheless, subsequent 
screening of conjugate reactive antibodies by 
CIEIA identified those with exclusive soman reac- 
tivity. We also found that a non-toxic soman 
analogue DPMP (methylphosphonic acid, di- 
[I ,2,2-trimethylpropyl] ester) could be substituted 
for soman in the CIEIA screen. However, some 
caution should be exercised in chasing monoclonal 
antibodies on the basis of analogue screening, in 
that antibodies may be selected that have higher af- 
finity for the analogue than for the compound of 
interest. 
There are advantages of monoclonal over poly- 
clonal antibodies in immunoassay procedures. The 
immortality of the hybridoma creates a continuous 
supply of monoclonal antibodies that are 
homogenous and facilitate precise quality control. 
Polyclonal antibodies, on the other hand, tend to 
change with each immunization, and such antisera 
decline in antibody activity between immuniza- 
tions. Monoclonal antibodies also exhibit high 
specificity in their binding as evidenced by the 
failure of monoclonal anti-soman antibody to bind 
sarin (fig. 3). In our earlier experiments, antisera 
raised in rabbits against the same soman-protein 
conjugates cross-reacted with a variety of organo- 
phosphorus compounds including sarin (unpub- 
lished). 
The CIEIA system is particularly well suited to 
detecting nerve agents. Unlike other immunoassay 
methods such as radioimmunoassay, CIEIA does 
150 
not require maintaining a supply of very toxic 
and labile radioactive organophosphonates. The 
soman-protein conjugates appear to be quite 
stable and are entirely non-toxic. The actual deter- 
mination of antibody binding can be done color- 
imetrically, thus avoiding the use of organic scin- 
tillation fluids and expensive counters. 
The CIEIA detected soman concentration as low 
as 1 .O x 10u6 M (200 ppb), and the standard curve 
generated was linear over 3 orders of magnitude. 
This allows for the preparation of dilutions of test 
samples over a wide concentration range with 
assurance that one or more values will fall on the 
standard curve. The assay was accomplished rapid- 
ly (2.5 h) and was highly reproducible. 
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